NEW YORK (GenomeWeb) – AMRI has announced a strategic alliance with Bruker Daltonics and HighRes Biosolutions to implement new mass spectrometry technology in drug discovery.

AMRI, a contract research organization, will implement Bruker Daltonics' MALDI PharmaPulse system at its Integrated Drug Discovery Center. Under the terms of the alliance, Bruker Daltonics and HighRes will train and consult with AMRI researchers as they develop protocols for high-throughput screening in drug discovery.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.